PHE to provide genomic sequencing support to partners across the world
Public Health England (PHE) has today announced the first group of countries who will receive genomic sequencing support through the New Variant Assessment Platform (NVAP).
Public Health England (PHE) has today announced the first group of countries who will receive genomic sequencing support through the New Variant Assessment Platform (NVAP).
Public Health England (PHE) has today announced the first group of countries who will receive genomic sequencing support through the New Variant Assessment Platform (NVAP).
Monthly counts of Clostridioides difficile (C. difficile) infections by NHS organisation and prior trust exposure (from April 2019) in patients aged 2 years and over.
Monthly counts of Pseudomonas aeruginosa (P. aeruginosa) bacteraemia by organisation and location of onset (from April 2019).
Monthly counts of meticillin-susceptible Staphylococcus aureus (MSSA) bacteraemia by organisation and location of onset (from April 2019).
Monthly counts of Escherichia coli (E.coli) bacteraemia by organisation and location of onset (from April 2019).
Monthly counts of Klebsiella species (Klebsiella spp.) bacteraemia by organisation and location of onset (from April 2019).
Monthly counts of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia by organisation and location of onset (from April 2019).